Radiation Oncology Mobile Application

Radiation Oncology Mobile Application: Symptoms Reporting System and Quality Assurance Tool

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03707860

Acronym

γ-App

Enrollment

Registered

2018-10-16

Start date

2019-02-01

Completion date

2021-10-20

Last updated

2022-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer, Radiation Toxicity

Brief summary

To develop a novel a mobile phone application (available on Android and IOS) for patients receiving radiation treatment for head and neck cancer. Through this application, patients will get access to their treatment calender, through a system connected with Mosiac database, which provides a timely and precise access to their treatments schedule. In addition, patients will be able to report their treatment related toxicity in real time fashion, these symptoms will be addressed daily instead of the weekly floor clinic checks. Furthermore, the radiation oncologist will receive an instant notification through the application, if there is error in patient's treatment (missing field, wrong dose, etc..)

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

Adult patients receiving definitive or adjuvant RT to head and neck site Chemotherapy is allowed PS:0-1 Has a smart phone

Exclusion criteria

Poor performance early laryngeal cancer Patient with metastatic disease, or palliative intent.

Design outcomes

Primary

Measure	Time frame	Description
Grade of symptoms improved with early intervention.	only during RT (7WEEKS)	using CTCAE v.5

Secondary

Measure	Time frame	Description
compliance on the mobile.	Only during RT (7WEEKS)	number of reports.

Countries

Jordan

Outcome results